Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

J Cai, H Chen, M Lu, Y Zhang, B Lu, L You, T Zhang… - Cancer letters, 2021 - Elsevier
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent
increase in pancreatic cancer incidence and mortality has resulted in an increased number …

Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis

P Yao, D Bennett, M Mafham, X Lin, Z Chen… - JAMA network …, 2019 - jamanetwork.com
Importance Vitamin D and calcium supplements are recommended for the prevention of
fracture, but previous randomized clinical trials (RCTs) have reported conflicting results, with …

Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology

MA Tempero, MP Malafa, M Al-Hawary… - Journal of the National …, 2021 - jnccn.org
Pancreatic cancer is the fourth leading cause of cancer-related death among men and
women in the United States. A major challenge in treatment remains patients' advanced …

Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer

NM Akella, L Ciraku, MJ Reginato - BMC biology, 2019 - Springer
Altered metabolism and deregulated cellular energetics are now considered a hallmark of
all cancers. Glucose, glutamine, fatty acids, and amino acids are the primary drivers of tumor …

Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations

N Mili, SA Paschou, DG Goulis, MA Dimopoulos… - Endocrine, 2021 - Springer
Overweight, obesity, and metabolic syndrome (MetS) have become epidemic conditions
affecting 39%, 13%, and 20% of the population respectively. The aim of this article is to …

The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study

R Carreras-Torres, M Johansson… - JNCI: Journal of the …, 2017 - academic.oup.com
Background Risk factors for pancreatic cancer include a cluster of metabolic conditions such
as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that …

Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data

VL Gordon-Dseagu, SS Devesa… - International journal …, 2018 - academic.oup.com
Background Annual pancreatic cancer incidence rates have been increasing. We examine
pancreatic cancer incidence trends by demographics and histologic type. Methods Data …

Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases

S Kim, BK Park, JH Seo, J Choi, JW Choi, CK Lee… - Scientific reports, 2020 - nature.com
Abstract Although carbohydrate antigen 19-9 (CA 19-9) may be elevated in benign
diseases, elevated CA 19-9 may cause a fear of cancer and unnecessary follow-up studies …

Epidemiology and burden of pancreatic cancer

P Maisonneuve - La Presse Médicale, 2019 - Elsevier
Pancreatic cancer, although infrequent, has a very poor prognosis, making it currently the
fourth common causes of cancer mortality in most developed countries including the …

In-situ dual-channel surface plasmon resonance fiber sensor for temperature-compensated detection of glucose concentration

S Wu, Q Tan, E Forsberg, S Hu, S He - Optics Express, 2020 - opg.optica.org
External temperature variations inevitably affect the accuracy of surface plasmon resonance
(SPR) biosensors. To that end, we propose an ultra-compact label-free dual-channel SPR …